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In a three-dimensional reconstructed human epidermis
filaggrin-2 is essential for proper cornification
V Pendaries1,2,3, M Le Lamer1,2,3, L Cau1,2,3, B Hansmann4, J Malaisse5, S Kezic6, G Serre1,2,3 and M Simon*,1,2,3
Atopic dermatitis is a chronic inflammatory skin disease with defects in the epidermal barrier. In a cohort of African-American
children, a FLG2 nonsense mutation has been associated with the disease. In the epidermis of European patients, the expression
of filaggrin-2, the filaggrin-related protein encoded by FLG2, is decreased. To describe the function of filaggrin-2 and evaluate the
impact of its deficiency, its expression was downregulated using lentivirus-mediated shRNA interference in a three-dimensional
reconstructed human epidermis (RHE) model. This resulted in parakeratosis and a compact stratum corneum, presence of
abnormal vesicles inside the corneocytes, increased pH and reduced amounts of free amino acids at the RHE surface, leading to
increased sensitivity to UVB radiations. The expression of differentiation markers was slightly modified. However, we observed
reduced proteolytic processing of corneodesmosin, hornerin and filaggrin in parallel with reduced amounts of caspase-14 and
bleomycin hydrolase. Our data demonstrated that filaggrin-2 is important for a proper cornification and a functional stratum
corneum. Its downregulation in atopic patients may be involved in the disease-associated epidermis impairment.
Cell Death and Disease (2015) 6, e1656; doi:10.1038/cddis.2015.29; published online 19 February 2015
Atopic dermatitis (AD; OMIM #603165), also known as atopic
eczema, is a very common inflammatory skin disease.1,2 It is
the result of complex interactions between genetic and
environmental factors. The most robust and widely replicated
genetic risk factor for the disease corresponds to nonsense
mutations of the gene FLG.3,4 This gene encodes filaggrin, an
S100 fused-type protein essential for the epidermal barrier
functions.3–5 Filaggrin deficiency is responsible for decreased
amounts of free amino acids in the stratum corneum (SC),6–9
abnormal keratinocyte differentiation,6,10 epidermal barrier
defects and enhanced percutaneous sensitization,6,7,9 all
characteristics of the atopic skin. However, a significant
number of Asian and European patients with AD do not
display any of the numerous known FLG mutations,3,4 in
particular in the South of Europe.11,12 In addition, FLG
nonsense mutations have not been detected in Ethiopian
and South African populations,13,14 and are not associated
with AD in African-American patients.15,16 Hence, the defect in
epidermal barrier functions of patients without FLGmutations,
including those of African ancestry, may be associated with
other inherited/acquired abnormalities that compromise kera-
tinocyte differentiation.17
Recently, mutations in the FLG2 gene, in particular a
nonsense mutation, were shown to be associated with
persistent AD in a cohort of 60 US patients of African
ancestry.18 FLG2 encodes filaggrin-2, another S100 fused-
type protein.19 Filaggrin-2 is very similar to filaggrin in terms of
protein structure, amino-acid composition, pattern of expres-
sion and of biochemical properties. It is synthetized by
granular keratinocytes as a large precursor consisting of 23
homologous repeats and a S100-homologous N-terminal
domain. Filaggrin-2 and filaggrin are colocalized in kerato-
hyalin granules in granular keratinocytes, and in the cytoplas-
mic matrix of the lower corneocytes.20,21 In the upper SC,
filaggrin-2 is deiminated and degraded by calpain 1.20 The role
of filaggrin-2 in the SC remains to be discovered, but it may be
similar to that of filaggrin.22 In addition, FLG2 is one of the
genes that are the most downregulated after cholesterol
depletion of keratinocytes, an experimental model of AD.23
Importantly, we and others have shown that filaggrin-2
expression is reduced, probably by pro-inflammatory cyto-
kines, in the epidermis of European patients.12,24
To analyze the function of filaggrin-2 and understand the
effect of its deficiency in AD in an immunological cell-free
context, we downregulated its expression with shRNA
technology in reconstructed human epidermis (RHE). This
technology has previously been used with success to
demonstrate the importance of filaggrin in the human
epidermis.6 The research focused particularly on epidermal
differentiation, SC properties and permeability barrier.
Results
Filaggrin-2 knockdown in RHE leads to a thinner
epidermis, parakeratosis, a compact SC and the pre-
sence of abnormal vesicles inside corneocytes. Filag-
grin-2 expression knockdown in RHE was achieved using
RNA interference in normal human primary keratinocytes that
were secondarily seeded on polycarbonate membranes and
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differentiated at the air–liquid interface for 10 days, as
previously described.6,25 This was performed with keratino-
cytes obtained from three different donors. Two shRNAs
targeting filaggrin-2 (shFLG2a and shFLG2b) were used
separately.
After 10 days of culture at the air–liquid interface of either
normal keratinocytes or keratinocytes transduced with a
control shRNA that does not target any known human gene,
morphologically differentiated RHEs were obtained. Proper
expression of differentiation markers and a functionally
competent SC were achieved, as reported before.6 In
particular, filaggrin and filaggrin-2 were detected in the stratum
granulosum with a granular pattern and in the SC
(Supplementary Figure S1a and Figure 1c). Similar locations
are known in the native epidermis, where the two proteins are
located in the keratohyalin granules and the corneocyte
matrix.19–21 The RHEs produced with keratinocytes trans-
duced with either the control shRNA (shc-RHE) or shFLG2a
(shFLG2-RHE) were analyzed by reverse transcription-
quantitative PCR (RT-qPCR) and western blotting with a
polyclonal antibody directed to filaggrin-2 (Figures 1a and b).
In shFLG2-RHE, filaggrin-2 mRNA and protein amounts
were decreased by 85% and 78%, respectively, compared
with shc-RHE. Although similar but not identical levels
of filaggrin-2 expression were observed in the RHEs
produced with keratinocytes from the three different donors
(Supplementary Figures S1b and c), the efficacy of down-
regulation was the same. Immunofluorescence labeling of
RHE sections showed the expression of filaggrin-2 in the
granular layers and SC. Confirming the efficacy of down-
regulation, the staining of shFLG2-RHE was markedly
reduced (Figure 1c). Similar results were obtained with
shFLG2b (illustrated in Supplementary Figure S2).
At a morphological level, shFLG2-RHE was thinner than
shc-RHE with a reduced thickness of the living keratinocyte
layers, as shown by hematoxylin–eosin staining (Figures 2a
and b). The SC thickness was identical, but parakeratosis was
evident in the shFLG2-RHE. To try to understand this effect on
epidermis thickness, the keratinocyte proliferation rate was
analyzed. Before epidermal reconstruction, no modification
was observed. However, in RHE at day 10, a significant
increase in Ki67 staining was observed (Supplementary
Figure S3). This indicated that the reduced thickness was
not due to reduced proliferation of the shFLG2-treated
keratinocytes.
Transmission electron microscopy analysis of shc- and
shFLG2-RHE (Figure 2c) showed similar keratinocyte organi-
zation and structures, including desmosomes, keratohyalin
granules and corneodesmosomes. However, at the lower
magnification, parakeratosis of shFLG2-RHE was confirmed
and the SC appeared denser without clear extracellular
spaces. At the highest magnification, abnormal material was
visible in the extracellular spaces, and the corneocytes
displayed unusual, large, intracellular vesicles.
The amino-acid content and pH of the upper SC are
disturbed in filaggrin-2-deficient RHE. To test for a
possible effect of filaggrin-2 knockdown on SC permeability,
we used the Lucifer yellow assay.9 At day 10, the hydrophilic
fluorescent dye was applied to the external surface of shc-
and shFLG2-RHE. As observed by fluorescence microscopy
(Figure 3a), the green dye was retained in the SC of both
control and filaggrin-2-deficient RHEs. In addition, Lucifer
yellow was hardly detectable in the culture medium
(Figure 3b). In contrast, large amounts of the dye were
detected when RHEs were analyzed at day 4 as a control.
This indicated that the outside-in permeability was not
affected by the deficiency in filaggrin-2.
Similar to filaggrin, filaggrin-2 has been suspected to be
degraded to free amino acids in the upper SC. These amino
acids and their derivatives may be involved in the acidification
of the SC and in the formation of natural moisturizing factor.
Therefore, we measured the pH at the external surface of the
shc- and shFLG2-RHE (Figure 3c). Filaggrin-2 inhibition
induced a statistically significant pH increase (mean value
from 6.38± 0.25 to 7.1± 0.15; P= 0.0075). Then, we quanti-
fied the contents of the urocanic acid and pyrrolidone
carboxylic acid in the RHE. HPLC analysis of RHE lysates
(Figure 3d) revealed a statistically significant urocanic acid
decrease in filaggrin-2-knockdown RHE as compared with the
control samples (from 5.90 to 4.80mmol/ml). Concerning the
pyrrolidone carboxylic acid concentration, a similar trend was
observed (from 47.66 to 40.68 mmol/ml) but the decrease did
Figure 1 Expression of filaggrin-2 is efficiently inhibited. (a) At day 10, fully
differentiated shc- and shFLG2-RHEs were analyzed by qRT-PCR. The expression of
the TATA box-binding protein gene was used for normalization. (b) Identical shc- and
shFLG2-RHEs were analyzed by western blot with a polyclonal antibody specific for
the spacer domain of filaggrin-2 (FLG2). A representative result is shown on the left.
Immunodetected filaggrin-2 was quantified and normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH) levels (shown on the right). (c) Identical shc-
and shFLG2-RHEs were analyzed by immunofluorescence with the same antibody. In
shc-RHE, filaggrin-2 was detected in the stratum granulosum with a granular labeling
(arrows and insert) and in the stratum corneum. The polycarbonate filter–epidermal
junction is indicated by a thin line. The mRNA and protein amounts corresponding to
shc-RHE were arbitrarily set at 100. The error bars correspond to the S.D. calculated
from independent experiments performed with keratinocytes from three different
donors, one being duplicated for qRT-PCR (n= 4) and each being duplicated for
western blotting (n= 6)
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not reach statistical significance. As urocanic acid is known to
protect skin against UVB radiation, we irradiated shc- and
shFLG2-RHE and detected active caspase-3 as a marker of
apoptosis, as previously described.6 Downregulation of
filaggrin-2 resulted in an increase in caspase-3 activation,
showing increased radiation sensitivity (Figures 3e and f).
Filaggrin-2 deficiency alters the epidermal differentiation
program. In order to test for a possible effect on keratinocyte
differentiation, the expression of a panel of genes differen-
tially expressed in the various layers of the epidermis was
explored at the mRNA level by quantitative real-time PCR
(Figure 4a). As compared with shc-RHE samples, mRNA
levels of loricrin, involucrin and E-cadherin were slightly
reduced in filaggrin-2-deficient RHE. The levels of mRNAs
encoding keratin (K)14, K10, desmoglein 1, desmocollin 1
and claudin 1 were not modified. To determine whether the
modifications at the mRNA level translated to the protein
level, western blotting was performed and the detected bands
were quantified (Figure 4b). Compared with controls, the
detection of loricrin was decreased in shFLG2-RHE. Inter-
estingly, the immunodetected claudin 1 amount was
increased by a factor of 3. The expression of K14, K10,
involucrin, desmoglein 1/2, desmocollin 1 and E-cadherin
was not modified.
It has been suggested that the expressions of filaggrin-2,
filaggrin and hornerin are coregulated.12 Therefore, we
investigated the expression of the last two S100 fused-type
proteins (Figure 5). No changes were detected at the mRNA
level, confirming the specificity of the shRNAs used (Figure 5a).
When shc- and shFLG2-RHE extracts were analyzed by
western blotting, different patterns of immunodetection were
Figure 2 Filaggrin-2 deficiency induces alteration in the epidermal morphology. (a) Stained sections of shc- and shFLG2-RHEs are shown (one representative experiment of
three). (b) Thickness of the living nucleated keratinocyte layers (LK), the stratum corneum (SC) and the total epidermis (E) were measured on images of five independent couples
of RHEs produced with keratinocytes from three different subjects. Differences in thickness values (n= 15) were analyzed using Student’s t-test. (c) RHEs were analyzed by
electron microscopy. Corneodesmosomes (cd), nuclear remnants (arrowheads and insert) and abnormal vesicles in the corneocyte matrix (black stars) are shown. Folded areas
of the sections are indicated by white asterisks. SG, stratum granulosum
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observed (Figure 5b). Profilaggrin was shown to accumulate
whereas filaggrin monomers were not detected and intermedi-
ates decreased by 52%. Similar results were obtained
concerning hornerin with an increase in the detection of the
entire protein (prohornerin) and a decrease of 60% in the
smaller bands. To test whether the proteolytic processing of
other epidermal proteins was affected by the knockdown of
filaggrin-2, we analyzed corneodesmosin in the same way
(Figures 5a and b, lower part). Whereas the corneodesmosin
mRNA amounts were similar, the entire 55 kDa protein
increased and the 40 kDa processed form decreased by 90%.
When indirect immunofluorescence analysis was performed
(Figure 5c), the labeling patterns obtained with the anti-filaggrin
and anti-hornerin antibodies were modified. Filaggrin and
hornerin were not detected in the SC of shFLG2-RHE but only
in the stratum granulosum, with a granular pattern suggesting
Figure 3 Filaggrin-2 knockdown leads to impaired stratum corneum properties. (a and b) A solution of Lucifer yellow was applied to the shc- and shFLG2-RHEs. After 6 h of
incubation, location of the dye was investigated using a fluorescence microscope (a) and dye concentration in the culture medium was quantified (b). As a control, a normal RHE
at day 4 was used (RHE-D4). (c) The pH was measured at the surface of the RHEs. Each indicated value corresponds to the mean pH of a different RHE (n= 5 shc-RHEs and
n= 6 shFLG2-RHEs). The RHEs were produced with keratinocytes from two different donors. (d) Pyrrolidone carboxylic acid (PCA) and urocanic acid (UCA) amounts were
quantified in lysates of shc-RHEs (n= 8) and shFLG2-RHEs (n= 9). RHEs were produced with keratinocytes from the same two different donors. (e) Active caspase-3 (red
staining; arrows) was detected without and with UVB irradiation, as indicated. Please note the nonspecific labeling of the polycarbonate membrane (under the thin line). (f) The
number of active caspase-3-positive cells was quantified and is indicated per RHE length unit. Differences in pH, in amino-acid amounts and in number of cells were analyzed
using Student’s t-test. Only statistically significant differences are indicated
Figure 4 Filaggrin-2 deficiency affects keratinocyte differentiation. (a) Expression of keratin (K)14 and differentiation-associated genes was analyzed by qRT-PCR in shc-
RHEs (black bars) and shFLG2-RHEs (gray bars). The expression of the TATA box-binding protein gene was used for normalization. *P= 0.041; **P= 0.005; ***P= 0.0036.
(b) Expression of the corresponding proteins was analyzed by western blotting, quantified and normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
immunoreactivity. **P= 0.0039; ***P= 5 × 10− 4. The mRNA and protein amounts corresponding to shc-RHE were arbitrarily set at 100. Mean values and S.D. (error bars) were
calculated from independent experiments performed with keratinocytes from three different donors, each being duplicated (n= 6). Data were compared using Student’s t-test.
Only statistically significant differences are indicated. LOR, loricrin; IVL, involucrin; DSG1, desmoglein 1; DSC1, desmocollin 1; CLDN1, claudin 1; CDH1, E-cadherin
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an accumulation of their respective proforms in the keratohyalin
granules. The distribution of corneodesmosin was not altered.
Procaspase-14 and bleomycin hydrolase expression is
reduced in shFLG2-RHE. Several proteases are known to
be involved in the processing of filaggrin, hornerin and
corneodesmosin, including caspase-14, bleomycin hydro-
lase, calpain 1 and kallikrein 7. To study the protease
deficiency in shFLG2-RHE, the expression of these enzymes
was analyzed by western blotting (Figure 6a). No differences
were observed for calpain 1 or kallikrein 7. Procaspase-14
and bleomycin hydrolase protein levels were reduced by 81%
and 69%, respectively, in shFLG2-RHE compared with shc-
RHE (Figure 6a). In the shFLG2-RHE, in addition to the
downregulation of procaspase-14, a reduction was observed
in the processing of the proform to the active form of the
protease (mean factor of 1.3±0.6; n=4). To determine
whether the observed modifications of enzyme expression
were because of changes in the corresponding mRNA levels,
a quantitative real-time PCR analysis was performed
(Figure 6b). Compared with control RHE samples, mRNA
levels of caspase-14 and bleomycin hydrolase were
significantly reduced in filaggrin-2-deficient RHE, whereas
mRNA levels of calpain and kallikrein 7 were not modified.
Discussion
Since the first description of the expression of FLG2 in
differentiated keratinocytes, little has been done to understand
the role of the encoded protein, filaggrin-2. However, the close
relationships between filaggrin and filaggrin-2 suggested that
the two proteins could play similar roles in the epidermal
barrier function.20,21 The recent descriptions of an association
between FLG2 nonsense mutations and disease persistence
in ADpatients of African ancestry, and of a reduced expression
of the protein in the epidermis of Caucasian patients,
prompted us to look for filaggrin-2 function using RHE as an
experimental model. We report here that filaggrin-2 knock-
down by RNA interference in RHE led to alterations in the
keratinocyte differentiation program. This culminated in
changes of SC morphology and functions. More particularly,
we observed changes in the amounts of loricrin and claudin 1,
defects in the proteolytic processing of filaggrin, hornerin and
corneodesmosin, and a compact SC with parakeratosis,
abnormal intracellular vesicles, a higher external surface pH
Figure 5 Filaggrin-2 deficiency leads to proteolytic processing defects. (a) Expression of filaggrin (FLG), hornerin (HRNR) and corneodesmosin (CDSN) genes was
investigated by qRT-PCR in shc- and shFLG2-RHEs. (b) Expression of the corresponding proteins was analyzed by western blotting and the indicated bands were quantified.
Error bars represent the S.D. (c) ProFLG/FLG, HRNR and CDSN expression patterns were investigated by immunohistology. The mRNA and protein amounts corresponding to
shc-RHE were arbitrarily set at 100. Mean values and S.D. (error bars) were calculated from independent experiments performed with keratinocytes from three different donors,
one being duplicated for qRT-PCR (n= 4) and each being duplicated for western blotting (n= 6). Data were analyzed using Student’s t-test. Only statistically significant
differences are indicated
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and decreased urocanic acid content. These data demon-
strate the importance of filaggrin-2 in cornification and suggest
its implication in AD pathophysiology.
Filaggrin-2 is composed of an NH2-terminal domain
homologous to S100 proteins and by two central domains
formed by repeated subunits. Because (1) the amino-acid
composition of filaggrin-2 B-type repeats is similar to that of
filaggrin, (2) filaggrin and filaggrin-2 B-type repeats are
concomitantly degraded in the upper SC and (3) both proteins
are substrates of calpain 1, it has been suggested that the
breakdown of filaggrin-2 into free amino acids contributes to
the production of natural moisturizing factor components,
control of the pH at the SC surface and photoprotection of the
epidermis.20,21 Supporting these hypotheses, the SC pH was
increased in filaggrin-2 knockdown RHE as compared with
control RHE, and the urocanic acid and pyrrolidone 5-
carboxylic acid contents were decreased. The decrease was
not so pronounced as by the FLG loss-of-function mutations
(i.e., one mutation results in ∼ 50% reduction) but is consistent
with their relative contribution to the risk for AD. In addition, we
observed an increased UVB-induced apoptosis of keratino-
cytes, urocanic acid being a major chromophore in the skin
protecting from UVB radiation.9
Many features indicated that the keratinocyte differentiation
program is perturbed when filaggrin-2 expression is down-
regulated. Such perturbations include a reduced expression of
loricrin at both the mRNA and protein levels and an apparent
stabilization of claudin 1. Many of them suggested premature
cornification: a reduced thickness of spinous/granular layers
without reduction of the keratinocyte proliferation rate,
persistence of nuclei (parakeratosis) and abnormal vesicles
in the corneocyte matrix and reduced proteolytic processing of
the late differentiation proteins (hornerin, profilaggrin and
corneodesmosin). An increased epidermal turnover has been
suggested to induce incomplete removal of organelles
because the cellular proteolytic machinery necessary for
protein/nucleic acid degradation is overfed.26 In an alternative
explanation, the expression of procaspase-14, the precursor
form, and of the processed form of caspase-14, the active form
of the protease, was highly reduced in shFLG2-RHE.
Caspase-14 deficiency has been reported to promote
parakeratosis in skin equivalent models treated with siRNA
and in knockout mice.27,28 Interestingly, parakeratosis has
also been described in some AD patients,29,30 in particular in
skin regions where caspase-14 was not detected.28
In order to understand the above-mentioned reduced
proteolytic processing of profilaggrin and corneodesmosin,
we investigated the expression of the respectively suspected
proteases, calpain 1 and kallikrein 7. The expression of both
proteases was similar in filaggrin-2 knockdown and control
RHE. Therefore, alterations in their activity and/or localization
could be supposed. As the pHwas increased in the filaggrin-2-
knockdown epidermis, and as kallikrein 7 has been reported to
bemore active at neutral than acidic pH, difference in the pH is
probably not the explanation. Another possibility concerning
kallikrein 7 is altered secretion. Loss of filaggrin-2 led to a
compact SC with apparently abnormal extracellular spaces
and the presence of intracellular large vesicles, suggestive of
abnormal secretion of lamellar body content. It has been
discussed how mutations in FLG, FATP4 and TMEM79 genes
and increase in SC pH converge to produce defective lamellar
body and/or to impair the secretion of these structures in
patientswith AD.17Mutations in FLG2 and reduced expression
of filaggrin-2 may well be involved.
When we compared the effects of filaggrin deficiency and
those of filaggrin-2 deficiency in RHE, some similarities were
observed (Figure 7 and Table 1), confirming that the proteins
are related. This induces a certain complexity in the
interpretation of the results. For example, are the reductions
in the level of natural moisturizing factor components and in
the expression of loricrin, bleomycin hydrolase and caspase-
14 directly because of the downregulation of filaggrin-2 or are
they a consequence of the reduced production of filaggrin
monomer or both? The increase of claudin-1, a tight junction
protein, suggests a compensatory mechanism to overcome
SC defects. However, the functions of filaggrin and filaggrin-2
are probably not identical as differences were also noted. In
particular, whereas filaggrin deficiency in RHEs and in a three-
dimensional skin model leads to enhanced penetration of
foreign molecules,6,31 filaggrin-2 knockdown appeared not to
disturb outside-in SC permeability: Lucifer yellowwas retained
in the SC of shFLG2- as well as shc-RHE. Modification of the
Figure 6 Expression of proteases is decreased in the absence of filaggrin-2. (a) Expression of caspase-14 (CASP14), bleomycin hydrolase (BLMH), calpain 1 (CAPN1) and
kallikrein 7 (KLK7) in shc- and shFLG2-RHE was analyzed by western blotting and quantified. Act C14, active processed form of CASP14. **P= 0.0004; **P= 7.8 × 10− 10;
***P= 8.09 × 10− 5. (b) Expression of the corresponding genes was investigated by qRT-PCR. *P= 3.06 × 10− 6; **P= 1.09 × 10− 5. The mRNA and protein amounts
corresponding to shc-RHE were arbitrarily set at 100. The error bars correspond to the S.D. calculated from independent experiments performed with keratinocytes from three
different donors, one being duplicated for qRT-PCR (n= 4) and each being duplicated for western blotting (n= 6). Data were analyzed using Student’s t-test. Only statistically
significant differences are indicated
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SC superficial pH was only observed when FLG2 was
downregulated. Hypogranulosis was only evidenced when
filaggrin was downregulated, even if filaggrin-2 is also a
component of keratohyalin granules,20,21 suggesting that the
former is much more abundant than the second. Accordingly,
the copy number of filaggrin mRNA per 10 ng of total RNA is
∼105,32 and that of filaggrin-2 is between 6 and 30.21
Some of the effects induced by filaggrin-2-deficiency
reproduced some AD-related epidermis alterations
(Table 1), as already mentioned, including parakeratosis, an
apparently reduced degradation of corneodesmosome com-
ponents including corneodesmosin,33 reduced amounts of
bleomycin hydrolase34 and natural moisturizing factor, altered
profilaggrin processing34 and the presence of vesicles inside
corneocytes.35 Similarly, the AD-associated increase in the
SC superficial pH36,37 could be because of the decrease in
filaggrin-2 amount, as it has not been observed in filaggrin-null
mice,7 filaggrin knockdown RHEs6 or patients with FLG
nonsense mutations.38
In conclusion, this study demonstrates that filaggrin-2 is
essential for normal keratinocyte differentiation, and that
filaggrin-2 downregulation may be responsible for reported
risk to AD.
Materials and Methods
shRNA lentiviral particles. For FLG2 knockdown in keratinocytes, we used
MISSION pLKO.1-puro vector based lentiviral particles containing a puromycin
resistance gene and a shRNA insert under the U6 promoter (Sigma-Aldrich,
St. Louis, MO, USA). Two shRNAs targeting exon 3 of FLG2 gene (shFLG2)
were tested (shFLG2a sequence: 5′-GATGATATTCAAGCTGACTAT-3′, nucleotide
position 301–321 on the mRNA sequence (NCBI reference NM_001014342.2);
Figure 7 Comparison of the effects of filaggrin-2 and filaggrin knockdown using shRNAs in reconstructed human epidermis. Similar consequences are indicated in bold.
BLMH, bleomycin hydrolase; FLG, filaggrin; LB, lamellar body; NMF, natural moisturizing factor. aPendaries et al6; bthis work
Table 1 Comparison of filaggrin-2 and filaggrin knockdown in reconstructed human epidermis with AD skin
Filaggrin-2 knockdown Filaggrin knockdowna ADb
Normal stratum granulosum Hypogranulosis Hypogranulosis
Parakeratosis and a compact stratum corneum Thin stratum corneum Some parakeratosis
Vesicles in corneocytes No vesicle in corneocytes Vesicles in corneocytes
Normal corneocyte matrix Disturbed corneocyte matrix Disturbed corneocyte matrix
Normal outside-in SC permeability Increased outside-in SC permeability Increased outside-in SC permeability
Reduced NMF level Reduced NMF level Reduced NMF level
Increased pH Unaffected pH Increased pH
Decreased amounts of bleomycin hydrolase Decreased amounts of bleomycin
hydrolase
Decreased amounts of bleomycin hydrolase
Reduced proteolysis of filaggrin and hornerin
precursors
Reduced expression of filaggrin-2
and hornerin
Reduced expression of filaggrin
and hornerin
abnormal (pro)filaggrin proteolysis
Reduced degradation of corneodesmosin Increased expression of corneodesmosin Persistence of corneodesmosomes
Reduced expression of loricrin Reduced expression of loricrin Reduced expression of loricrin
Abnormal expression of tight junction proteins Abnormal expression of tight junction
proteins
Abnormal expression of tight junction
proteins
Abbreviation: NMF, natural moisturizing factor
See aPendaries et al 6 and bOyoshi et al2and Guttman-Yassky et al40 and references in the text
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shFLG2b sequence: 5′-CAGTTGGGAAAGAAGGAAAGATTT-3′, nucleotide position
763–783). A nontarget shRNA that does not target any known human gene (shc)
was used as a control (5′-CCGGCAACAAGATGAAGAGCACCAACTC-3′).
Keratinocyte culture and transduction. Primary normal human kerati-
nocytes were obtained from abdominal dermolipectomy of three different healthy
subjects who had given their informed consent. They were cultured and transduced
with the lentivirus containing either shFLG2a, shFLG2b or shc at a multiplicity of
infection of 10 in the presence of 4 μg/ml of protamine sulfate, as described
previously.6 After selection in the presence of puromycin, keratinocytes were used to
produce RHE on polycarbonate filters as described previously.25 Briefly, cells were
harvested by trypsinization, and 350 000 cells in ice-cold EpiLife medium (Invitrogen
Life Technologies) containing 1.5 mM calcium were seeded on polycarbonate
culture inserts (area of 0.63 cm2 with pores 0.4 μm in diameter; Merck Millipore,
Bedford, MA, USA). After 24 h of incubation at 37°C in a humidified atmosphere
containing 5% CO2, cells were exposed to the air–liquid interface, and 50 μg/ml
vitamin C (Sigma-Aldrich) and 10 ng/ml keratinocyte growth factor (Sigma-Aldrich)
were added to the medium in the lower compartment. The medium was renewed
every 2 days during the 10 days of air–liquid interface culture.
Immunostaining. At day 10, RHEs were fixed with 4% formaldehyde-
containing buffer, and paraffin embedded. After deparaffinization and hydration,
sections were blocked with PBS containing 2% bovine serum albumin and
incubated with primary antibodies (Supplementary Table S1). After incubation with
the corresponding secondary antibody (Alexa Fluor 555 anti-Rabbit IgG, Alexa Fluor
555 or 488 anti-Mouse IgG, Alexa Fluor 555 or 488 anti-Goat IgG, Invitrogen Life
Technologies), nuclei were stained with DAPI (Sigma-Aldrich) and the slides were
observed with a Nikon Eclipse 80i fluorescence microscope equipped with a Nikon
DXM 1200 digital camera (Nikon, Tokyo, Japan).
Morphological analysis. Epidermal thickness was assessed using images of
hematoxylin–eosin-stained sections of paraffin-embedded RHEs, counting three
fields per slide. Experiments were performed with keratinocytes from the three
volunteers. Transmission electron microscopy analysis was carried out as previously
described.6 Briefly, samples were fixed with 2.5% glutaraldehyde-formaldehyde
solution, washed with Sorensen phosphate buffer, post-fixed with 1% OsO4,
dehydrated and embedded in EmBed 812 resin (Electron Microscopy Sciences,
Hatfield, PA, USA). Ultrathin sections were mounted on 100-mesh collodion-coated
copper grids and post-stained with 3% uranyl acetate and 8.5% lead citrate before
being examined with a Hitachi HT7700 electron microscope (Hitachi, Tokyo, Japan).
Western blotting. At day 10, RHEs were lysed in 100 μl of Laemmli buffer.
Total epidermal proteins were separated on acrylamide gels and immunodetected
with the primary antibodies and peroxidase-conjugated secondary antibodies (Goat
anti-rabbit IgG-HRP and swine anti-goat IgG-HRP, SouthernBiotech, Birmingham,
AL, USA; goat anti-mouse IgG-HRP, Bethyl Laboratories, Montgomery, TX, USA).
Reaction products were detected by chemiluminescence with the ECL kit (Pierce/
Thermo Scientific, Rockford, IL, USA). Quantity One 1-D Analysis Software (Bio-
Rad Laboratories, Hercules, CA, USA) was used to quantify immunoreactive bands
on western blot films after scanning. Signals were normalized to glyceraldehyde 3-
phosphate dehydrogenase immunodetection.
Reverse transcription-quantitative PCR. Reverse transcription (RT)
was performed as previously described.6 The primers used are listed in the
Supplementary Table S2. Only Ct values between 17 and 26 were considered.
Relative levels of gene expression among samples were determined with the ΔΔ
cycle threshold method. TATA box binding protein (TBP) gene expression was used
for normalization.
Analysis of Lucifer yellow permeability. At day 10, 200 μl of 1 mM
Lucifer yellow (Sigma-Aldrich) was added onto the SC of the RHEs. After incubation
at 37°C for 6 h, the RHEs were fixed in 4% formaldehyde and embedded in paraffin.
Sections were inspected under the fluorescence microscope. In parallel, the dye
concentration in the culture medium was measured fluorometrically in a fluoroscan
(Varioskan Flash, Thermo Fisher Scientific, Rockford, IL, USA) with excitation at
425 nm and emission at 550 nm.
Determination of the pH at the RHE surface. At day 10, the pH at the
RHE surface was determined with a pH electrode (Skin-pH-Meter PH 905, Courage
+Khazaka Electronic GmbH, Köln, Germany).
Determination of the urocanic acid and pyrrolidone carboxylic
acid contents. At day 10, RHE specimens were lysed in 0.1 M KOH and amino
acids were analyzed by HPLC as previously described.8,39
Statistical analysis. Statistical differences were determined with Student’s
t-test. A value of Po0.05 was considered statistically significant.
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